Tesamorelin
Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH). It stimulates endogenous growth hormone production.
- Reduction of visceral adipose tissue
- IGF-1 modulation
- Central adiposity
- Metabolic concerns
Therapy requires careful screening.
Compounded tesamorelin is not FDA-approved for general weight loss or anti-aging. Prescribed only under medical supervision.
Medical evaluation: $99
Labs may be required before prescribing.
How It Works
You’ll begin with a brief virtual consultation with a licensed medical provider, who will review your medical history and determine whether this therapy may be appropriate for you.
If treatment is recommended, your prescription is sent to a licensed U.S. compounding pharmacy and shipped directly to your home, typically within 3–7 business days.
Consultation Cost
The total cost is $300, which includes:
If a peptide therapy is not clinically appropriate, there is no charge for the visit.
- All therapies are prescribed only when clinically appropriate and based on physician evaluation.
Frequently Asked Questions
Tesamorelin is FDA-approved for specific medical conditions, but compounded versions are not approved for general weight loss or anti-aging use.
Tesamorelin can be prescribed legally under physician supervision when appropriate clinical criteria are met.
It is administered as a subcutaneous injection, typically on a daily basis.
Individuals with certain metabolic or endocrine conditions require careful evaluation before considering therapy.